
Oxford Finance LLC
Description
Oxford Finance LLC is a prominent specialty finance firm based in Alexandria, Virginia, dedicated to providing senior secured debt capital to healthcare and life sciences companies. Unlike traditional venture capital firms that focus on equity investments, Oxford Finance offers flexible debt solutions, including term loans, revolving lines of credit, and venture debt, tailored to the unique needs of companies ranging from clinical-stage biotechs to commercial-stage medical device and healthcare service providers. Their expertise lies in understanding the complex regulatory and commercial landscapes of these sectors, enabling them to structure financing that supports product development, commercialization, and general corporate purposes without significant equity dilution.
With a robust track record, Oxford Finance has established itself as a significant capital provider in the life sciences and healthcare ecosystem. The firm has deployed over $12 billion in capital since its inception, demonstrating its long-standing commitment and capacity to support innovation and growth within these critical industries. This substantial capital deployment highlights their deep industry relationships and ability to execute complex financing arrangements for a diverse portfolio of companies. Their strategic approach often involves partnering with venture capital and private equity firms, complementing equity rounds with debt financing.
Oxford Finance typically provides loan facilities ranging from $5 million to $150 million, catering to a broad spectrum of company sizes and stages within their target sectors. Their financing solutions are designed to be non-dilutive, offering an attractive alternative or complement to equity funding for companies seeking to extend their cash runway, fund clinical trials, or scale commercial operations. In 2023 alone, Oxford Finance committed over $2.5 billion in new debt facilities, underscoring their active role and continued expansion in the market. Their due diligence process is rigorous, focusing on intellectual property, management teams, and market potential to ensure the viability of their portfolio companies.
Investor Profile
Oxford Finance LLC has backed more than 155 startups, with 3 new investments in the last 12 months alone. The firm has led 70 rounds, about 45% of its total and boasts 91 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Debt Financing, Post Ipo Debt, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Ireland.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 3 rounds in the past year.
- Typical check size: $5M – $150M.
Stage Focus
- Debt Financing (54%)
- Post Ipo Debt (37%)
- Series Unknown (4%)
- Series B (2%)
- Post Ipo Equity (1%)
- Series E (1%)
- Series C (1%)
- Series A (1%)
Country Focus
- United States (92%)
- United Kingdom (4%)
- Ireland (1%)
- Canada (1%)
- The Netherlands (1%)
- Switzerland (1%)
- Germany (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Biopharma
- Life Science
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.